A detailed history of Jpmorgan Chase & CO transactions in Organovo Holdings, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 73 shares of ONVO stock, worth $33. This represents 0.0% of its overall portfolio holdings.

Number of Shares
73
Previous 63 15.87%
Holding current value
$33
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$0.75 - $1.35 $7 - $13
10 Added 15.87%
73 $0
Q1 2024

May 10, 2024

BUY
$0.9 - $1.17 $8 - $10
9 Added 16.67%
63 $0
Q4 2023

Feb 12, 2024

BUY
$1.05 - $1.84 $4 - $7
4 Added 8.0%
54 $0
Q3 2023

Nov 14, 2023

BUY
$1.06 - $1.9 $10 - $19
10 Added 25.0%
50 $0
Q1 2023

May 11, 2023

SELL
$1.44 - $3.2 $144 - $320
-100 Reduced 71.43%
40 $0
Q4 2022

Feb 13, 2023

BUY
$1.41 - $2.17 $141 - $217
100 Added 250.0%
140 $0
Q3 2021

Nov 12, 2021

BUY
$6.08 - $8.92 $243 - $356
40 New
40 $0

Others Institutions Holding ONVO

About ORGANOVO HOLDINGS, INC.


  • Ticker ONVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,712,020
  • Market Cap $4.01M
  • Description
  • Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...
More about ONVO
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.